Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Recovery in Meniscectomy
NCT05280236Completed
- Sponsor
- Yonsei University
- Start
- Mar 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of remimazolam in meniscus injury (2 arms), sponsored by Yonsei University. Primary endpoint: Quality of Recovery-40 questionnaire. Started Mar 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
meniscus injury
Beyond the preview
Go deeper on NCT05280236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05280236.